1. Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer
   Si Yeon Song et al, 2022, Integrative Cancer Therapies CrossRef
2. 22-O-(N-Boc-l-glycine) ester of renieramycin M inhibits migratory activity and suppresses epithelial–mesenchymal transition in human lung cancer cells
   Yamin Oo et al, 2021, Journal of Natural Medicines CrossRef
3. Fast Simultaneous Determination of 3 Major Components (Ginsenosides Rg1, Rb1, and Rc) after Oral Administration of HAD-B1 in Rats Using the HPLC-MS/MS System
   Lien Thi Ngo et al, 2022, Drug Targets and Therapeutics CrossRef